--- title: "QDEL.US (QDEL.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/QDEL.US/news.md" symbol: "QDEL.US" name: "QDEL.US" parent: "https://longbridge.com/en/quote/QDEL.US.md" datetime: "2026-03-12T10:46:15.054Z" locales: - [en](https://longbridge.com/en/quote/QDEL.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/QDEL.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/QDEL.US/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/QDEL.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/QDEL.US/news.md) # QDEL.US (QDEL.US) — Related News ### [Rice Hall James Buys QuidelOrtho Stock](https://longbridge.com/en/news/278401305.md) *2026-03-09T13:35:18.000Z* > Rice Hall James & Associates, LLC purchased 574,877 shares of QuidelOrtho (NASDAQ:QDEL) in Q4 2025, increasing their tot ### [Lantheus Earnings: What To Look For From LNTH](https://longbridge.com/en/news/276823655.md) *2026-02-25T03:08:52.000Z* > Lantheus Holdings is set to report earnings this Thursday, with analysts expecting a 6.3% revenue decline year-on-year, ### [Quidelortho Faces Material Risk from Weak Internal Controls and Sarbanes–Oxley Compliance Challenges](https://longbridge.com/en/news/276415474.md) *2026-02-20T06:05:41.000Z* > Quidelortho Corporation (QDEL) has revealed a significant risk related to its internal controls and compliance with the ### [QuidelOrtho Corp launched episode 56 on Science Bytes podcast featuring Dr. Lindy Carlstrom, discussing high-sensitivity troponin for faster cardiac answers.](https://longbridge.com/en/news/276346375.md) *2026-02-19T14:19:50.000Z* > San Diego-based QuidelOrtho Corporation, a prominent player in the field of in vitro diagnostics and listed on Nasdaq un ### [Faster Cardiac Answers with High‑Sensitivity Troponin | QDEL Stock News](https://longbridge.com/en/news/276344467.md) *2026-02-19T06:17:00.000Z* > QuidelOrtho Corporation (Nasdaq: QDEL) has released episode 56 of its Science Bytes podcast, featuring Dr. Lindy Carlstr ### [01:00 ETQuidelOrtho geht strategische Liefervereinbarung zur Erweiterung des globalen Immunoassay-Portfolios ein](https://longbridge.com/en/news/276035325.md) *2026-02-16T06:05:37.000Z* > QuidelOrtho has entered into a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. to expand its g ### [QuidelOrtho partners with Lifotronic Technology Co., Ltd. to expand immunoassay portfolio globally, adding analyzer platforms and assay menu.](https://longbridge.com/en/news/276036065.md) *2026-02-16T06:03:33.000Z* > In a recent announcement on February 16, 2026, QuidelOrtho disclosed a strategic partnership with Lifotronic Technology